News Focus
News Focus
Post# of 257255
Next 10
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

Re: jq1234 post# 129542

Thursday, 10/27/2011 10:35:49 AM

Thursday, October 27, 2011 10:35:49 AM

Post# of 257255
Right, so state of play as I understand it:

PFE: JAK1/JAK3/TYK2 (with some impact on JAK2)
INCY: JAK1/JAK2
VRTX: JAK3

JAK3 is expressed only in immune cells. INCY made a big deal of their compound not hitting JAK3, but I'm not really seeing any evidence yet to support their theory.

Here's an article discussing some of the initial work in the field:

http://pubs.acs.org/cen/business/88/8839bus2.html

Note the idea of combining with an HSP90 drug - this is a recurring theme I keep seeing in many different areas.

Peter





Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now